Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FB9QJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,366
Award facts
- Contract value 100% obligated
- $16,366.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,366.12 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of TRELEGY ELLIPTA 200-62.5-25 inhalation powder (60-dose units). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of January 13, 2026, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the Defense Logistics Agency's Medical Supply Chain, which serves military healthcare systems and related federal medical institutions.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the supply of diverse pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally. This delivery order for TRELEGY ELLIPTA, a combination respiratory medication used to treat chronic obstructive pulmonary disease, exemplifies the routine pharmaceutical procurement executed through this comprehensive contract vehicle to support federal medical operations.
Quick answers
Who was awarded contract SPE2DR26FB9QJ?
SPE2DR26FB9QJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FB9QJ worth?
The government has obligated $16,366 on SPE2DR26FB9QJ.
Is contract SPE2DR26FB9QJ an order under another contract?
Yes. SPE2DR26FB9QJ is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9QJ competed?
The extent of competition for SPE2DR26FB9QJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award